Abstract
Lercanidipine is a 1,4-dihydropyridine calcium channel blocker. For severe toxicity, treatment modalities are based on a restricted range of evidence and clinical experience. This case report describes our clinical experience regarding the treatment of Lercanidipine overdose in a 16-year-old girl. To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine.
Keywords: Lercanidipine, intoxication, child, treatment
Copyright and license
Copyright © 2022 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.
